
Wolverine combines BPC-157 and TB-500 to support multiple pathways involved in physical recovery.
BPC-157 is associated with tissue-response, vascular, collagen, and connective-tissue pathways, while TB-500–related pathways are associated with cellular migration, angiogenesis, and tissue-remodeling processes. PubMed
Together, they create a broader recovery-focused approach than either peptide alone, making Wolverine well suited for patients focused on mobility, physical resilience, and staying active.
Wolverine may support:
• Physical recovery• Muscle and connective-tissue wellness
• Joint and mobility goals
• Post-exercise recovery
• Tissue resilience
• Active-lifestyle performance
Your provider can personalize the treatment schedule based on your goals and response.
Your provider will review your medical history, medications, previous injuries or procedures, and treatment goals before prescribing.
Discuss pregnancy or breastfeeding, cancer history, significant cardiovascular, liver or kidney conditions, or previous reactions to injectable or peptide therapies.
Prescription required.